10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0000721371-21-000011`
Period End Date	20201231
Filing Date	20210205
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	cah-20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 88 Cash Flow Statement 64 Stockholders Equity 57 Comprehensive Income 28

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.74B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.66B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$8.26B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$8.73B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	34.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	33.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$14.44B	USD	Point-in-time
Inventories, net	`InventoryNet`	$13.20B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.71B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$3.21B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$30.11B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.94B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.39B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.37B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$11.10B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$11.28B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.19B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.12B	USD	Point-in-time
Total assets	`Assets`	$40.77B	USD	Point-in-time
Total assets	`Assets`	$44.72B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$23.23B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.37B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$10.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$13.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.50B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.23B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$25.75B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.61B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$6.72B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$6.76B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.59B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$10.27B	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2020 and June 30, 2020, respectively	`CommonStockValue`	$2.79B	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2020 and June 30, 2020, respectively	`CommonStockValue`	$2.78B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.17B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.25B	USD	Point-in-time
Common shares in treasury, at cost: 33 million shares and 34 million shares at December 31, 2020 and June 30, 2020, respectively	`TreasuryStockValue`	$2.01B	USD	Point-in-time
Common shares in treasury, at cost: 33 million shares and 34 million shares at December 31, 2020 and June 30, 2020, respectively	`TreasuryStockValue`	$2.07B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-53.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-104.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$1.97B	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$1.79B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$3.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$4.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.43B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$40.77B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$44.72B	USD	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	34.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	33.00M	shares	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$80.61B	USD	2 Qtrs
Revenue	`Revenues`	$41.54B	USD	1 Quarter
Revenue	`Revenues`	$39.73B	USD	1 Quarter
Revenue	`Revenues`	$77.08B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$39.77B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$73.68B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$77.11B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$38.02B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.49B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.71B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.78B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.39B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.15B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.27B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.28B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.16B	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$56.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$57.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$20.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$86.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$116.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$133.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$265.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$234.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	-	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-8.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-7.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-9.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-21.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-1.07B	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-32.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-5.69B	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$334.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$-163.00M	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$-4.93B	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$461.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$12.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$12.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$19.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-2.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$129.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$63.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$46.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$91.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.00M	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$427.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-5.07B	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$279.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-236.00M	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$364.00M	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$203.00M	USD	1 Quarter
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$613.00M	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-59.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$377.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$630.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-4.70B	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$376.00M	USD	2 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$220.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$629.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-4.70B	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-15.99	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.28	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$2.14	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.75	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.75	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.27	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$2.13	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-15.99	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	294.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	292.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	293.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	294.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	294.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	295.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	294.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	295.00M	shares	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.97	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.49	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.48	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.96	USD	2 Qtrs

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$377.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$630.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-4.70B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$404.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$464.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	-	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-8.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-7.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-9.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.00M	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$51.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$41.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$35.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$47.00M	USD	2 Qtrs
(Increase)/decrease in trade receivables	`IncreaseDecreaseInReceivables`	$-121.00M	USD	2 Qtrs
(Increase)/decrease in trade receivables	`IncreaseDecreaseInReceivables`	$499.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$991.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.26B	USD	2 Qtrs
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-77.00M	USD	2 Qtrs
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.86B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-504.00M	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-5.13B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.49B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$44.00M	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.00M	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$174.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$149.00M	USD	2 Qtrs
Purchase of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$6.00M	USD	2 Qtrs
Purchase of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$18.00M	USD	2 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$2.00M	USD	2 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$4.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	-	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	$2.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-191.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-151.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$681.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$793.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$49.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-6.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-11.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$287.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$289.00M	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$350.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-344.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-760.00M	USD	2 Qtrs
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-5.00M	USD	2 Qtrs
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$14.00M	USD	2 Qtrs
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$966.00M	USD	2 Qtrs
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-872.00M	USD	2 Qtrs
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.74B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.66B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.74B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.66B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time

Stockholders Equity 57 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.43B	USD	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	34.00M	shares	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	33.00M	shares	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$2.01B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$2.07B	USD	Point-in-time
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$220.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$377.00M	USD	2 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$630.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-4.70B	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$376.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$220.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$629.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-4.70B	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-2.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$34.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-24.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$51.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$51.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-2.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-24.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$34.00M	USD	1 Quarter
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodSharesShareBasedCompensation`	2.00M	shares	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$46.00M	USD	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$23.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$30.00M	USD	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$30.00M	USD	1 Quarter
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$350.00M	USD	2 Qtrs
Dividends	`Dividends`	$289.00M	USD	2 Qtrs
Dividends	`Dividends`	$284.00M	USD	2 Qtrs
Dividends	`Dividends`	$143.00M	USD	1 Quarter
Dividends	`Dividends`	$144.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-2.00M	USD	2 Qtrs
Other	`StockholdersEquityOther`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	$1.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$1.00M	USD	2 Qtrs
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.43B	USD	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	34.00M	shares	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	33.00M	shares	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$2.01B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$2.07B	USD	Point-in-time
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$350.00M	USD	2 Qtrs
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	-	USD	1 Quarter

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$377.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$630.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-4.70B	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$21.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-18.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$33.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-6.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$18.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$13.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-2.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$34.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-24.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$51.00M	USD	2 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$664.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.72B	USD	2 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$428.00M	USD	2 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$218.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-4.73B	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$663.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$427.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$218.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.